Jaguar Health (JAGX) Total Liabilities (2014 - 2026)
Jaguar Health (JAGX) reported Total Liabilities of $53.2 million for Q1 2026, up 10.47% year-over-year from $48.1 million in Q1 2025, and down 6.71% quarter-over-quarter from $57.0 million in Q4 2025.
Jaguar Health (JAGX) Total Liabilities (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Total Liabilities data on file, last reported at $53.2 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $53.2 million, up 10.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.2 million (up 10.47% YoY), and the FY2025 annual result was $57.0 million, up 28.27% from the prior year.
- Total Liabilities eased to $53.2 million in Q1 2026 per JAGX's latest filing, from $57.0 million in the prior quarter.
- Over five years, Total Liabilities peaked at $57.0 million in Q4 2025 and troughed at $41.1 million in Q1 2024.
- A 5-year average of $46.4 million and a median of $45.9 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities decreased 16.61% in 2024, then increased 28.27% in 2025.
- A 5-year view of Total Liabilities shows it stood at $48.8 million in 2022, then dropped by 6.03% to $45.9 million in 2023, then decreased by 3.1% to $44.4 million in 2024, then gained by 28.27% to $57.0 million in 2025, then decreased by 6.71% to $53.2 million in 2026.
- Business Quant data shows JAGX's Total Liabilities at $53.2 million in Q1 2026, $57.0 million in Q4 2025, and $45.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 137.56 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 53.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.19 Mn |
| Dec 31, 2025 | 57.01 Mn |
| Sep 30, 2025 | 45.11 Mn |
| Jun 30, 2025 | 41.39 Mn |
| Mar 31, 2025 | 48.15 Mn |
| Dec 31, 2024 | 44.45 Mn |
| Sep 30, 2024 | 42.88 Mn |
| Jun 30, 2024 | 42.40 Mn |
| Mar 31, 2024 | 41.09 Mn |
| Dec 31, 2023 | 45.87 Mn |
| Sep 30, 2023 | 43.96 Mn |
| Jun 30, 2023 | 46.34 Mn |
| Mar 31, 2023 | 49.27 Mn |
| Dec 31, 2022 | 48.81 Mn |
| Sep 30, 2022 | 47.69 Mn |
| Jun 30, 2022 | 47.13 Mn |
| Mar 31, 2022 | 44.80 Mn |
| Dec 31, 2021 | 41.41 Mn |
| Sep 30, 2021 | 37.70 Mn |
| Jun 30, 2021 | 37.75 Mn |